RETRACTED: Amorphous Selenium Nanoparticles Improve Vascular Function in Rats With Chronic Isocarbophos Poisoning via Inhibiting the Apoptosis of Vascular Endothelial Cells
A Retraction of the Original Research Article
Amorphous selenium nanoparticles improve vascular function in rats with chronic isocarbophos poisoning via inhibiting the apoptosis of vascular endothelial cells
by Zhu M, Gao Z, Fu Y, Qiu Y, Huang K, Zhu C, Wu Y, Zhu T, Wang Q, Yang L, Yin Y and Li P (2021). Front. Bioeng. Biotechnol. 9:673327. doi: 10.3389/fbioe.2021.673327
Following publication, concerns were raised regarding the integrity of the images in the published figures.
The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.
The retraction of the article was approved by the Chief Editor of Frontiers in Bioengineering and Biotechnology and the Chief Executive Editor of Frontiers. The authors did not respond to the retraction.
Citation: Frontiers Editorial Office (2024) Retraction: Amorphous selenium nanoparticles improve vascular function in rats with chronic isocarbophos poisoning via inhibiting the apoptosis of vascular endothelial cells. Front. Bioeng. Biotechnol. 12:1450363. doi: 10.3389/fbioe.2024.1450363
Received: 17 June 2024; Accepted: 17 June 2024;
Published: 01 July 2024.
Approved by:
Gianni Ciofani, Italian Institute of Technology (IIT), ItalyCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==